Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Patent Growth for CurieAI

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

May 21, 2020

Founded in 2018, CurieAI is a health-monitoring start-up which was spun out of SRI International. CurieAI provides a respiratory health platform with intelligent health monitoring, intended to enable proactive interventions to improve patient health. The company utilizes passive continuous monitoring, a web platform for clinicians, and a patient mobile app.

CurieAI believes its AI-solution improves patient compliance, helps healthcare systems better manage the chronic diseases population, and reduces the total cost of care. Now, it is backing that up with a significant investment in IP. Recently, the company had five applications published which teach patient monitoring and personalized treatment recommendation.

During the COVID-19 pandemic, the company has made its Curie Respiratory Care app available to individuals for personal monitoring.  It will monitor for respiratory symptoms caused by COVID-19 via the user's smartphone and will provide alerts to seek medical attention. The app is compatible with devices including the Apple Watch, Fitbit, and pulse oximeters to better analyze respiratory status.


Relevant Patent Documents

Application US20200152226  

Application US20200151519  

Application US20200151516  

Application US20200146623  

Application US20200152330  


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301